Here's something I would like the opponents of authorized generics to explain: Why is it ok for generic drug companies to divy up the profits during the exclusivity period after a Para 4 challenge but not for an innovator company to introduce it's own generic version that does the same thing?
To wit from Beth McClean's article about Apopletic's Bernie Sherman in Fortune:
"Because they (meaning the generic firms) had all filed on the same day, they would have had to share the 180-day period - meaning profits would have been slim even during the period of supposed exclusivity."
The high price of drug patents
To wit from Beth McClean's article about Apopletic's Bernie Sherman in Fortune:
"Because they (meaning the generic firms) had all filed on the same day, they would have had to share the 180-day period - meaning profits would have been slim even during the period of supposed exclusivity."
The high price of drug patents
